Table 1 Comparison of the basic and clinical characteristics of patients not treated with MTX (Group 1), treated with MTX by intramuscular injection (Group 2) or treated with MTX by intravenous injection (Group 3)
Mean ± SD/Rate | P value | |||
|---|---|---|---|---|
Group 1(n = 47) | Group 2(n = 46) | Group 3(n = 14) | ||
Age (years) | 32.04 ± 6.283 | 31.15 ± 5.597 | 34.14 ± 4.865 | 0.206 |
Previous cesarean section (n) | 1.17 ± 0.380 | 1.17 ± 0.383 | 1.57 ± 0.514 | 0.004 |
Gravidity (n) | 4.13 ± 1.24 | 4.20 ± 1.470 | 5.0 ± 1.519 | 0.186 |
Parity (n) | 1.21 ± 0.414 | 1.22 ± 0.513 | 1.50 ± 0.519 | 0.08 |
Gestational age at diagnosis (days) | 52.68 ± 11.66 | 48.76 ± 8.945 | 52.15 ± 13.619 | 0.292 |
Fetal heart beat positive, n (%) | 15(31.9%) | 21(45.7%) | 5(35.7%) | 0.466 |